title: Footrace to clinic heats up for T-cell nuclear receptor inhibitors.
authors: Cormac
authors: C
authors: Sheridan
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology*; D015195:Drug Design; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D038622:Internationality; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3 / Q000037:antagonists & inhibitors* / Q000276:immunology*
chemical_list: D007155:Immunologic Factors; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3
references: Science. 2009 Jun 5;324(5932):1334-8
references: 19498172
references: Nat Biotechnol. 2011 Aug 05;29(8):679
references: 21822233
references: Nat Biotechnol. 2012 Jun 07;30(6):475-7
references: 22678368